Prophylactic neuroprotection with A91 improves the outcome of spinal cord injured rats

Neuroscience Letters

Volumn 554, Issue , 2013, Pages 59-63

  Ibarra, A ^a,b   Sosa, M ^a   Garcia E ^a,b   Flores, A ^a,b   Cruz, Y ^a   Mestre, H ^a   Martinon S ^b   Pineda Rodriguez B A ^a   Gutierrez Ospina G ^c  

^a UNIVERSIDAD ANÁHUAC   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

A91; Neural constituents; Paraplegia; Prophylactic neuroprotection; Protective autoimmunity; Vaccination

Indexed keywords

A91 VACCINE; NEUROPROTECTIVE AGENT; PEPTIDE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IMMUNIZATION; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; RAT; RUBROSPINAL TRACT; SPINAL CORD INJURY; SPINAL CORD VENTRAL HORN;

A91; BASSO, BEATTIE & BRESNAHAN OPEN-FIELD TEST; BBB; BD; BOOSTER DOSE; CARBOXIFLUORESCEIN DIESTER AMINE; CFA; CFSE; COMPLETE FREUND'S ADJUVANT; MBP; METHYLPREDNISOLONE; MP; MYELIN BASIC PROTEIN; NEURAL CONSTITUENTS; OVA; OVALBUMIN; PARAPLEGIA; PROPHYLACTIC NEUROPROTECTION; PROTECTIVE AUTOIMMUNITY; RSNS; RUBROSPINAL NEURONS; SC; SD; SINGLE DOSE; SPINAL CORD; VACCINATION; VENTRAL HORN NEURONS; VHNS;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; IMMUNIZATION, SECONDARY; MYELIN BASIC PROTEIN; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; T-LYMPHOCYTES; VACCINES;

EID: 84884379398     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.08.048     Document Type: Note

References (20)

1. Delank K.S., Delank H.W., Konig D.P., Popken F., Furderer S., Eysel P. Iatrogenic paraplegia in spinal surgery. Arch. Orthop. Trauma Surg. 2005, 125:33-41.
2. Alcanyis-Alberola M., Giner-Pascual M., Salinas-Huertas S., Gutierrez-Delgado M. Iatrogenic spinal cord injury: an observational study. Spinal Cord 2011, 49:1188-1192.
3. Chen Q., Li F., Wu W. Risk factors of iatrogenic spinal cord injury in spinal surgery: a multicenter retrospective study. Int. J. Neurosci. 2012, 122:606-610.
4. Guizar-Sahagun G., Rodriguez-Balderas C.A., Franco-Bourland R.E., Martinez-Cruz A., Grijalva I., Ibarra A., Madrazo I. Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions. Spinal Cord 2009, 47:156-160.
5. Hauben E., Agranov E., Gothilf A., Nevo U., Cohen A., Smirnov I., Steinman L., Schwartz M. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest. 2001, 108:591-599.
6. Ziv Y., Avidan H., Pluchino S., Martino G., Schwartz M. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. PNAS 2006, 103:13174-13179.
7. Martinon S., Garcia E., Gutierrez-Ospina G., Mestre H., Ibarra A. Development of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury. PLoS ONE 2012, 7:e32027.
8. Ibarra A., Garcia E., Flores N., Martinon S., Reyes R., Campos M.G., Maciel M., Mestre H. Immunization with neural-derived antigens inhibits lipid peroxidation after spinal cord injury. Neurosci. Lett. 2010, 476:62-65.
9. Garcia E., Silva-Garcia R., Mestre H., Flores N., Martinon S., Calderon-Aranda E.S., Ibarra A. Immunization with A91 peptide or copolymer-1 reduces the production of nitric oxide and inducible nitric oxide synthase gene expression after spinal cord injury. J. Neurosci. Res. 2012, 90:656-663.
10. Del Rayo G.M., Silva-Garcia R., Garcia E., Martinon S., Morales M., Mestre H., Flores-Dominguez C., Flores A., Ibarra A. Therapeutic window for combination therapy of A91 peptide and glutathione allows delayed treatment after spinal cord injury. Basic Clin. Pharmacol. Toxicol. 2013, 112:314-318.
11. Ibarra A., Hauben E., Butovsky O., Schwartz M. The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. Eur. J. Neurosci. 2004, 19:2984-2990.
12. Martinon S., Garcia E., Flores N., Gonzalez I., Ortega T., Buenrostro M., Reyes R., Fernandez-Presas A.M., Guizar-Sahagun G., Correa D., Ibarra A. Vaccination with a neural-derived peptide plus administration of glutathione improves the performance of paraplegic rats. Eur. J. Neurosci. 2007, 26:403-412.
13. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 1995, 12:1-21.
14. Teng Y.D., Mocchetti I., Wrathall J.R. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur. J. Neurosci. 1998, 10:798-802.
15. Shaked I., Tchoresh D., Gersner R., Meiri G., Mordechai S., Xiao X., Hart R.P., Schwartz M. Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J. Neurochem. 2005, 92:997-1009.
16. Jones T.B., Basso D.M., Sodhi A., Pan J.Z., Hart R.P., MacCallum R.C., Lee S., Whitacre C.C., Popovich P.G. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J. Neurosci. 2002, 22:2690-2700.
17. Ibarra A., Correa D., Willms K., Merchant M.T., Guizar-Sahagun G., Grijalva I., Madrazo I. Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Brain Res. 2003, 979:165-178.
18. Hauben E., Ibarra A., Mizrahi T., Barouch R., Agranov E., Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. PNAS 2001, 98:15173-15178.
19. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 2000, 20:6421-6430.
20. Hauben E., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 2000, 355:286-287.